Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo targets Hard-to-Treat bowel cancer

NCT ID NCT04689347

First seen Jan 12, 2026 · Last updated Apr 29, 2026 · Updated 17 times

Summary

This study is for people with a specific type of advanced colorectal cancer that has spread. It tests a new combination of chemotherapy drugs and a targeted therapy to see if it is safe and works better than current treatments. The goal is to control the cancer and improve survival. About 27 people will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione IRCCS Istituto Nazionale dei Tumori

    RECRUITING

    Milan, Milan, 20133, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Istituto Oncologico Veneto IRCCS

    RECRUITING

    Padova, PD, 35128, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ospedale Santa Chiara

    RECRUITING

    Pisa, PI, 56126, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.